Drugs / RO7070179
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02564614 | May 2016 → Jan 2018 | hepatocellular carcinoma | Hoffmann-La Roche | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RO7070179 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02564614 ↗ |